RE:Horrendous Close Ironically they spent $1.1billion on Cannimed, and now the combined company (and others) is worth less than that. How times have changed. Also shows ACB's growth strategy of buying everything in sight only worked as long as they were buying sh$t, a bit like a ponzi, as long as there was some new news and excitement, the stock went up.